Yipinhong Pharmaceutical Co Ltd Class A (300723) — Capital Reinvestment Ratio

Latest as of September 2025: 0.91x

Yipinhong Pharmaceutical Co Ltd Class A (300723) has a Capital Reinvestment Ratio of 0.91x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥14.81 Million) in capital expenditures (CN¥13.52 Million). Check Yipinhong Pharmaceutical Co Ltd Class A (300723) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.91x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥14.81 Million
CNY

Capital Expenditures

CN¥13.52 Million
CNY

Data as of

Sep 2025
Most recent filing

Yipinhong Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio (2013–2025)

This chart tracks Yipinhong Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Yipinhong Pharmaceutical Co Ltd Class A.

Annual Capital Reinvestment Ratio for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

Year-by-year Capital Reinvestment Ratio for Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025. See 300723 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 2.76x CN¥46.01 Million CN¥127.21 Million ▲ +278.6%
2023 0.73x CN¥458.05 Million CN¥334.46 Million ▼ -42.7%
2022 1.27x CN¥475.53 Million CN¥605.78 Million ▼ -0.6%
2021 1.28x CN¥438.10 Million CN¥561.23 Million ▲ +12.2%
2020 1.14x CN¥275.22 Million CN¥314.15 Million ▲ +204.5%
2019 0.37x CN¥280.65 Million CN¥105.22 Million ▼ -65.2%
2018 1.08x CN¥238.60 Million CN¥256.77 Million ▲ +434.0%
2017 0.20x CN¥141.35 Million CN¥28.49 Million ▲ +3.1%
2016 0.20x CN¥146.01 Million CN¥28.55 Million ▼ -84.0%
2015 1.23x CN¥34.55 Million CN¥42.33 Million ▼ -90.5%
2014 12.84x CN¥8.74 Million CN¥112.21 Million ▲ +1888.5%
2013 0.65x CN¥135.68 Million CN¥87.58 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow